ALSC provides life sciences companies and investors with a new approach to consulting and due diligence. Our guiding principle is that the best advice requires both rigorous scientific and technical expertise and a keen appreciation for the critical business and operational considerations.
Serving the biopharmaceutical industry, industry associations and academic institutions, we sit within the Healthcare & Science division of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals. We help our clients define, manage and mitigate their most pressing business challenges in R&D and clinical operations.
Our solutions, technology and consulting for life sciences organizations can help you improve clinical development processes, act on insights to drive growth, and enhance relationships across the ecosystem.